GRN and neurodegenerative disease: Low plasma progranulin levels, once used to predict an underlying GRN mutation in the pre‐next generation sequencing era and its biological effect, have been demonstrated in a wide range of neurodegenerative diseases, postulating a role of PGRN as a risk factor for neurodegeneration.9